Linking white matter integrity loss to associated cortical regions using structural connectivity information in Alzheimer's disease and fronto-temporal dementia: The Loss in Connectivity (LoCo) score

NeuroImage

Volumn 61, Issue 4, 2012, Pages 1311-1323

  Kuceyeski, Amy ^a   Zhang, Yu ^b,c   Raj, Ashish ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Fronto temporal dementia; Loss in Connectivity (LoCo) score; Network disruption; Neurodegenerative diseases; Spatially unbiased methods; Structural brain connectivity networks; Tractography

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN REGION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; LOSS IN CONNECTIVITY SCORE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRUCTURAL NUCLEAR MAGNETIC RESONANCE IMAGING; TRACTOGRAPHY; WHITE MATTER;

ALZHEIMER DISEASE; ATROPHY; CEREBRAL CORTEX; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84861369880     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.03.039     Document Type: Article

References (70)

1. Acosta-Cabronero J., Williams G., Pengas G., Nestor P. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010, 133:529-539.
2. Agosta F., Scola E., Canu E., Marcone A., Magnani G., Sarro L., Copetti M., Caso F., Cerami C., Comi G., Cappa S.F., Falini A., Filippi M. White matter damage in Frontotemporal Lobar degeneration spectrum. Cereb. Cortex 2011, 10.1093/cercor/bhr288.
3. Alemán-Gómez Y., Melie-García L., Valdés-Hernandez P. IBASPM: Toolbox for automatic parcellation of brain structures. Presented at the 12th Annual Meeting of the Organization for Human Brain Mapping. Florence, Italy 2005.
4. Apostolova L., Steiner C., Akopyan G., Dutton R., Hayashi K., Toga A., Cummings J., Thompson P. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch. Neurol. 2007, 64:1489-1495. 10.1001/archneur.64.10.1489.
5. Avants B., Cook P., Ungar L., Gee J., Grossman M. Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. NeuroImage 2010, 50(3):1004-1016.
6. Bendlin B., Ries M., Canu E., Sodhi A., Lazar M., Alexander A., Carlsson C., Sager M., Asthana S., Johnson S. White matter is altered with parental family history of Alzheimer's disease. Alzheimer's & dementia. J. Alzheimer's Assoc. 2010, 6(5):9. 10.1016/j.jalz.2009.11.003.
7. Boccardi M., Laakso M., Bresciani L., Galluzzi S., Geroldi C., Beltramello A., Soininen H., Frisoni G. The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia. Neurobiol. Aging 2003, 24(1):95-103.
8. Borroni B., Brambati S., Agosti C., Gipponi S., Bellelli G., Gasparotti R., Garibotto V., Di Luca M., Scifo P., Perani D., Padovani A. Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch. Neurol. 2007, 64(2):246-251. (February).
9. Bozzali M., Parker G.J., Serra L., Embleton K., Gili T., Perri R., Caltagirone C., Cercignani M. Anatomical Connectivity Mapping: a new tool to assess brain disconnection in Alzheimer's Disease. NeuroImage 2011, 54(3):2045-2051.
10. Braak H., Del Tredici K., Schultz C., Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann. N. Y. Acad. Sci. 2000, 924:53-61.
11. Brun A., Englund E. Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods. Prog. Neuropsychopharmacol. Biol. Psychiatry 1986, 10(3-5):297-308.
12. Buckner R., Snyder A., Shannon B., LaRossa G., Sachs R., Fotenos A., Sheline Y., Klunk W., Mathis C., Morris J., Mintun M. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25(34):7709-7717.
13. Chételat G., Desgranges B., Landeau B., Mézenge F., Poline J.B., De La Sayette V., Viader F., Eustache F., Baron J.-C. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008, 131(1):60-71.
14. Davatzikos C., Resnick S., Wu X., Parmpi P., Clark C. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. NeuroImage 2008, 41(4):1220-1227.
15. Davatzikos C., Wu X., An Y., Fan Y., Resnick S. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 2009, 132(8):2026-2035.
16. de Leon M., DeSanti S., Zinkowski R., Mehta P., Pratico D., Segal S., Rusinek H., Li J., Tsui W., Saint Louis L., Clark C., Tarshish C., Li Y., Lair L., Javier E., Rich K., Lesbre P., Mosconi L., Reisberg B., Sadowski M., DeBernadis J., Kerkman D., Hampel H., Wahlund L.-O., Davies P. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol. Aging 2006, 27(3):394-401.
17. Douaud G., Jbabdi S., Behrens T., Menke R., Gass A., Monsch A., Rao A., Whitcher B., Kindlmann G., Matthews P., Smith S. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. NeuroImage 2011, 55(3):880-890.
18. Englund E., Brun A., Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 1988, 111(6):1425-1439.
19. Fischl B., Salat D., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
20. Folstein M., Folstein S., McHugh P. Mini-mental state. J. Psychiatr. Res. 1975, 12(3):189-198. November.
21. Forman M., Zhukareva V., Bergeron C., S-M Chin S., Grossman M., Clark C., M.-Y. Lee V., Trojanowski J. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am. J. Pathol. 2002, 160(6):2045-2053. June.
22. Forman M., Farmer J., Johnson J., Clark C., Arnold S., Coslett H., Chatterjee A., Hurtig H., Karlawish J., Rosen H., Van Deerlin V., M.-Y. Lee V., Miller B., Trojanowski J., Grossman M. Fronto-temporal dementia: clinicopathological correlations. Ann. Neurol. 2006, 59(6):952-962.
23. Frisoni G., Prestia A., Rasser P., Bonetti M., Thompson P. In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. J. Neurol. 2009, 256(6):916-924.
24. Friston K., Ashburner J., Kiebel S., Nichols T., Penny W. Statistical Parametric Mapping: The Analysis of Functional Brain Images 2006, Academic Press.
25. Frost B., Diamond M. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 2010, 11(3):155-159.
26. Genovese C., Lazar N., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 2002, 15(4):870-878.
27. Gili T., Cercignani M., Serra L., Perri R., Giove F., Maraviglia B., Caltagirone C., Bozzali M. Regional brain atrophy and functional disconnection across Alzheimer's disease evolution. J. Neurol. Neurosurg. Psychiatry 2011, 82(1):58-66.
28. Gold B., Powell D., Andersen A., Smith C. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. NeuroImage 2010, 52(4):1487-1494.
29. Griswold M., Jakob P., Heidemann R., Nittka M., Jellus V., Wang J., Kiefer B., Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002, 47(6):1202-1210.
30. Hornberger M., Geng J., Hodges J. Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia. Brain 2011, 134(9):2502-2512.
31. Iturria-Medina Y., Canales-Rodriguez E., Melie-Garcia L., Valdes-Hernandez P. Bayesian formulation for fiber tracking. NeuroImage 2005, 26. Available on CD-Rom, (1).
32. Jack C.R., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., Smith G.E., Ivnik R.J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997, 49(3):786-794.
33. Jeong Y., Cho S., Park J., Kang S., Lee J., Kang E., Na D., Kim S. 18F-FDG PET Findings in Frontotemporal Dementia: an SPM analysis of 29 patients. J. Nucl. Med. 2005, 46(2):233-239.
34. Klauschen F., Goldman A., Barra V., Meyer-Lindenberg A., Lundervold A. Evaluation of automated brain MR image segmentation and volumetry methods. Hum. Brain Mapp. 2009, 30(4):1310-1327. 10.1002/hbm.20599.
35. Krueger C., Dean D., Rosen H., Halabi C., Weiner M., Miller B., Kramer J. Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 2011, 24(1):43-48.
36. Krzanowski W.J. Principles of Multivariate Analysis: A User's Perspective 1988, Clarendon Press.
37. Kuceyeski A., Raj A. Investigating correlations of cortical atrophy and white matter integrity loss in Alzheimer's subjects using connectivity information. Alzheimer's Association International Conference on Alzheimer's Disease, 16242. Paris, France 2011.
38. Kuceyeski A., Maruta J., Niogi S., Ghajar J., Raj A. The generation and validation of white matter connectivity importance maps. NeuroImage 2011, 58(1):109-121. 10.1016/j.neuroimage.2011.05.087.
39. Kuczynski B., Targan E., Madison C., Weiner M., Zhang Y., Reed B., Chui H., Jagust W. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimer's & dementia. J. Alzheimer's Assoc. 2010, 6(1):54-62. 10.1016/j.jalz.2009.04.1228.
40. Larsson E., Englund E., Sjöbeck M., Lätt J., Brockstedt S. MRI with diffusion tensor imaging post-mortem at 3.0T in a patient with frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 2004, 17(4):316-319.
41. Liu L., Drouet V., Wu J., Witter M., Small S., Clelland C., Duff K. Trans-synaptic spread of tau pathology. PLoS ONE 2012, 7:e31302. (2).
42. Masutani Y., Aoki S., Abe O., Hayashi N., Otomo K. MR diffusion tensor imaging: recent advance and new techniques for diffusion tensor visualization. Eur. J. Radiol. 2003, 46(1):53-66.
43. Matsuo K., Mizuno T., Yamada K., Akazawa K., Kasai T., Kondo M., Mori S., Nishimura T., Nakagawa M. Cerebral white matter damage in frontotemporal dementia assessed by diffusion tensor tractography. Neuroradiology 2008, 50(7):605-611.
44. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-944.
45. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. NeuroImage 2009, 44(4):1415-1422.
46. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43(11):2412-2414.
47. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51(6):1546-1554.
48. Neumann M., Kwong L., Truax A., Vanmassenhove B., Kretzschmar H., Van Deerlin V., Clark C., Grossman M., Miller B., Trojanowski J., Lee V. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 2007, 66(3):177-183.
49. Oishi K., Faria A., Jiang H., Li X., Akhter K., Zhang J., Hsu J., Miller M., van Zijl P., Albert M., Lyketsos C., Woods R., Toga A., Pike G., Rosa-Neto P., Evans A., Mazziotta J., Mori S. Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's' disease participants. NeuroImage 2009, 486-499.
50. Pearson R.C., Esiri M.M., Hiorns R.W., Wilcock G.K., Powell T.P. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1985, 82(13):4531-4534.
51. Pereira J., Xiong L., Acosta-Cabronero J., Pengas G., Williams G., Nestora P. Registration accuracy for VBM studies varies according to region and degenerative disease grouping. NeuroImage 2010, 49(3):2205-2215.
52. Raj A., Mueller S.G., Young K., Laxer K.D., Weiner M. Network-level analysis of cortical thickness of the epileptic brain. NeuroImage 2010, 52(4):1302-1313.
53. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., Steinling M., Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 1993, 114(1):7-12.
54. Seeley W., Crawford R., Zhou J., Miller B., Greicius M. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009, 62(1):42-52.
55. Smith S., Jenkinson M., Woolrich M., Beckmann C., Behrens T., Johansen-Berg H., Bannister P., De Luca M., Drobnjak I., Flitney D., Niazy R., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23(Suppl. 1):S208-S219. 10.1016/j.neuroimage.2004.07.051.
56. Smith C., Chebrolu H., Andersen A., Powell D., Lovell M., Xiong S., Gold B. White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging 2010, 31(7):1122-1131.
57. Stricker N.H., Schweinsburg B.C., Delano-Wood L., Wierenga C.E., Bangen K.J., Haaland K.Y., Frank L.R., Salmon D.P., Bondi M.W. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. NeuroImage 2009, 45(1):10-16.
58. Thompson P., Hayashi K., de Zubicaray G., Janke A., Rose S., Semple J., Herman D., Hong M., Dittmer S., Doddrell D., Toga A. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23(3):994-1005.
59. Villain N., Desgranges B., Viader F., de la Sayette V., Mézenge F., Landeau B., Baron J., Eustache F., Chételat G. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J. Neurosci. 2008, 28(24):6174-6181. 10.1523/JNEUROSCI.1392-08.2008.
60. Villain N., Fouquet M., Baron J., Mézenge F., Landeau B., de La Sayette V., Viader F., Eustache F., Desgranges B., Chételat G. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain 2010, 133(11):3301-3314.
61. Weiner M., Veitch D.P., Aisen P.S., Beckett L.A., Cairns N.J., Green R.C., Harvey D., Jack C.R., Jagust W., Liu E., Morris J.C., Petersen R.C., Saykin A.J., Schmidt M.E., Shaw L., Siuciak J.A., Soares H., Toga A.W., Trojanowski J.Q., Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & dementia. J. Alzheimer's Assoc. 2012, 8(1 Suppl.):S1-S68.
62. Whitwell J., Avula R., Senjem M., Kantarci K., Weigand S., Samikoglu A., Edmonson H., Vemuri P., Knopman D., Boeve B., Petersen R., Josephs K., Jack C. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology 2010, 74(16):1279-1287.
63. Wu M., Rosano C., Lopez-Garcia P., Carter C., Aizenstein H. Optimum template selection for atlas-based segmentation. NeuroImage 2007, 34(4):1612-1618. 10.1016/j.neuroimage.2006.07.050.
64. Xie S., Xiao J., Wang Y., Hong Kun W., Gong G., Jiang X. Evaluation of bilateral cingulum with tractography in patients with Alzheimer's disease. Neuroreport 2005, 16(12):1275-1278.
65. Yasmin H., Nakata Y., Aoki S., Abe O., Sato N., Nemoto K., Arima K., Furuta N., Uno M., Hirai S., Masutani Y., Ohtomo K. Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract. Neuroradiology 2008, 50(4):293-299. 10.1007/s00234-007-0353-7.
66. Yoshiura T., Mihara F., Koga H., Noguchi T., Togao O., Ohyagi Y., Ogomori K., Ichimiya A., Kanba S., Honda H. Cerebral white matter degeneration in frontotemporal dementia detected by diffusion-weighted magnetic resonance imaging. Acad. Radiol. 2006, 13(11):1373-1378.
67. Zhang Y., Schuff N., Jahng G.-H., Bayne W., Mori S., Schad L., Mueller S., Du A., Kramer J., Yaffe K., Chui H., Jagust W., Miller B., Weiner M. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68(1):13-19. 10.1212/01.wnl.0000250326.77323.01.
68. Zhang Y., Schuff N., Du A., Rosen H., Kramer J., Gorno-Tempini M., Miller B., Weiner M. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 2009, 132(9):2579-2592.
69. Zhang Y., Schuff N., Ching C., Tosun D., Zhan W., Nezamzadeh M., Rosen H., Kramer J., Gorno-Tempini M.L., Miller B.L., Weiner M. Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int. J. Alzheimer's Dis. 2011, 546871. 10.4061/2011/546871.
70. Zhou J., Greicius M., Gennatas E., Growdon M., Jang J., Rabinovici G., Kramer J., Weiner M., Miller B., Seeley W. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010, 133(5):1352-1367.